Predicting 90-day survival of patients with COVID-19:
Survival of Severely Ill COVID (SOSIC) scores
by Matthieu Schmidt, Bertrand Guidet, Alexandre Demoule, Maharajah Ponnaiah, Muriel Fartoukh, Louis Puybasset, Alain Combes and David Hajage
Annals of
Intensive Care volume 11,
Article number: 170 (2021) Published: 11
December 2021
Predicting outcomes of critically ill intensive care unit
(ICU) patients with coronavirus-19 disease (COVID-19) is a major challenge to
avoid futile, and prolonged ICU stays.
Methods
The objective was to develop predictive survival models for
patients with COVID-19 after 1-to-2 weeks in ICU. Based on the COVID–ICU
cohort, which prospectively collected characteristics, management, and outcomes
of critically ill patients with COVID-19. Machine learning was used to develop
dynamic, clinically useful models able to predict 90-day mortality using ICU
data collected on day (D) 1, D7 or D14.
Results
Survival of Severely Ill COVID (SOSIC)-1, SOSIC-7, and
SOSIC-14 scores were constructed with 4244, 2877, and 1349 patients,
respectively, randomly assigned to development or test datasets. The three
models selected 15 ICU-entry variables recorded on D1, D7, or D14.
Cardiovascular, renal, and pulmonary functions on prediction D7 or D14 were
among the most heavily weighted inputs for both models. For the test dataset,
SOSIC-7’s area under the ROC curve was slightly higher (0.80 [0.74–0.86]) than
those for SOSIC-1 (0.76 [0.71–0.81]) and SOSIC-14 (0.76 [0.68–0.83]).
Similarly, SOSIC-1 and SOSIC-7 had excellent calibration curves, with similar
Brier scores for the three models.
Conclusion
The SOSIC scores showed that entering 15 to 27 baseline and
dynamic clinical parameters into an automatable XGBoost algorithm can
potentially accurately predict the likely 90-day mortality post-ICU admission
(sosic.shinyapps.io/shiny). Although external SOSIC-score validation is still
needed, it is an additional tool to strengthen decisions about life-sustaining
treatments and informing family members of likely prognosis.
No comments:
Post a Comment